Current Report Filing (8-k)
March 09 2018 - 4:18PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 8, 2018
THE COOPER COMPANIES, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
1-8597
|
|
94-2657368
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification Number)
|
6140 Stoneridge Mall Road, Suite 590, Pleasanton, California 94588
(Address of principal executive offices, including Zip Code)
(925)
460-3600
(Registrants telephone number, including area code)
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of
this chapter).
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financing accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
On March 8, 2018, The Cooper Companies, Inc. (the Company) announced that
its Board of Directors (its Board) has named Albert G. White III as the President and Chief Executive Officer (CEO) of the Company, effective May 1, 2018. Mr. White will succeed Robert S. Weiss, who will retire as
President and CEO, effective April 30, 2018.
Mr. White, 49, has served as Chief Financial Officer since November 2016. He also serves as
Executive Vice President and Chief Strategy Officer, positions he has held since December 2015 and July 2011, respectively. Since August 2015, Mr. White also oversees and directs our womens healthcare business and is currently CEO of
Cooper Medical, Inc., the parent company to CooperSurgical, Inc. Previously, he served as Vice President, Investor Relations from November 2007 through March 2013 and as Vice President and Treasurer from April 2006 through December 2012. Prior to
joining the Company, Mr. White was a Director with KeyBanc Capital Markets for three years and held a number of leadership positions within KeyBank National Association over the prior eight years.
Mr. Whites current compensation is set forth in the Companys proxy statement filed with the Securities Exchange Commission on
February 2, 2018.
ITEM 7.01. Regulation FD Disclosure.
On March 8, 2018, the Company issued a press release announcing the appointment of Mr. White and the retirement of Mr. Weiss. A copy of the press release is
attached hereto as Exhibit 99.1 and is incorporated herein by reference. Internet addresses in the release are for information purposes only and are not intended to be hyperlinks to other The Cooper Companies, Inc. information.
The information in this report furnished pursuant to Item 7.01, including Exhibit 99.1 attached hereto, will not be deemed filed for the purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the
Securities Act of 1933, as amended, if such subsequent filing specifically references the information furnished pursuant to Item 7.01 of this Current Report on Form 8-K.
ITEM 9.01. Financial Statements and Exhibits.
(d)
Exhibits.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
THE COOPER COMPANIES, INC.
|
|
|
|
|
Dated: March 9, 2018
|
|
|
|
By:
|
|
/s/ Albert G. White, III
|
|
|
|
|
|
|
Albert G. White, III
|
|
|
|
|
|
|
Executive Vice President, Chief Financial Officer
and Chief Strategy Officer
|
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Apr 2023 to Apr 2024